Sandhu, K., Real, M. D., Macias, A., Zhang, J., Ng, K., Kim, Y., Akhtari, M., Egelston, C., Nanhwan, M., Palmer, J., Robbins, M., Aribi, A., Mei, M., Salhotra, A., Amanam, I., Agrawal, V., Arslan, S., Ball, B., Otoukesh, S., Koller, P., Pourhassan, H., Ali, H., Becker, P., Pullarkat, V., Forman, S., Aldoss, I., Stein, A. S., Marcucci, G., Budde, E. (2025). High efficacy of blinatumomab combined with pembrolizumab in patients with relapsed/refractory (r/r) B cell acute lymphoblastic leukemia (B-ALL): primary analysis of a Phase 1/2 study. Blood. https://doi.org/10.1182/blood-2025-3352